The FDA is seeking advice this week from two of its advisory committees on how manufacturers of a major group of asthma drugs should study their potential risks.
FDA Panels to Advise on LABA Study DesignsCourtesy MedPage Today Allergy & Immunology Tue, 03/09/2010 - 15:39
The FDA is seeking advice this week from two of its advisory committees on how manufacturers of a major group of asthma drugs should study their potential risks. More related itemsBeta-2 Receptor Variants Don't Affect LABA Response...
...
FDA Approves No-Comb Treatment for Head Lice
Finger Pulse Oximeter Octive Tech 300C with Hard...
New 2009 Hi Bebe BT-200 Fetal Doppler/Heart Rate...
|
Popular by tags Month |
Post new comment